Nicole Fawcett

Director of Communications, University of Michigan Rogel Cancer

Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.

Portrait of Max Wicha, founding director of Rogel Cancer Center
Health Lab

‘We might for the first time really be thinking of cures of cancer’

Founding Rogel Cancer Center Director reflects on how cancer evolved from ‘the least scientific discipline’ to a shining example of how basic research discoveries can change clinical care.
colorful drawing of people figures dark background
Health Lab

Everyone plays a role in improving cancer health equity

As guest editor for a themed journal issue, Lori Pierce helps highlight the multiple factors that can make cancer care and prevention more equitable and reduce the burden of this disease for all
green background intestines in pink
Health Lab

Researchers identify why cancer immunotherapy can cause colitis

Researchers at the University of Michigan Health Rogel Cancer Center have identified a mechanism that causes severe gastrointestinal problems with immune-based cancer treatment, also finding a way to deliver immunotherapy’s cancer-killing impact without the unwelcome side effect.
green blue map of michigan
Health Lab

How does exposure to ‘forever chemicals’ impact your cancer risk

Pearce, professor of epidemiology at the School of Public Health and co-lead of Rogel’s cancer control and population sciences program, reflects on the project and why bringing this study to Michigan is so critical.
IV drip
Health Lab

Monitoring program flags cancer patients at risk of highly toxic chemotherapy side effects

Researchers from the University of Michigan Health Rogel Cancer Center have developed a monitoring system using a research genetics program to trigger alerts about cancer patients suspected to have the DPYD gene variant.
Health Lab

Prescription drugs too costly? Changing your health plan could save money

For people with expensive prescription drugs, switching plans could save them thousands of dollars in copays. And a simple tool can help people easily compare out-of-pockets expenses for anyone with a Medicare Part D prescription plan.
HistoSonics Edison platform
News Release

U-M Health to purchase Edison platform for histotripsy, following FDA approval

Technology developed at U-M uses sound waves to destroy tissue, providing a new type of cancer therapy
family tree shown and written on paper with a pen
News Release

New study aims to help families statewide understand their cancer risk

Historically, genetic testing for cancer risk has been underutilized, especially in underserved communities. The MiGHT Project aims to help Michigan residents at increased risk of cancer get access to clinical genetic testing.
man at table writing down in living room
Health Lab

Free online tool helps prostate cancer patients save on out-of-pocket drug costs

A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a Michigan Medicine study finds.
glioma brain scan
Health Lab

Study finds improved survival for incurable brain tumor, providing ‘a crack in the armor’

A potential drug candidate called ONC201 nearly doubled survival for patients with diffuse midline glioma and DIPG.
money pills cancer vial yellowArtboard
Health Lab

Changing the way immune-based cancer drugs are delivered could reduce costs by 14%

An analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered.
Illustrated picture of the Rogel Cancer Center building
News Release

Rogel Cancer Center awarded $37M from NCI

5-year support grant renews center’s ‘comprehensive’ status, represents 40 years of continuous funding
Rogel Cancer Center illustration
News Release

Rogel Cancer Center awarded $37M from NCI

The National Cancer Institute has awarded the U-M Rogel Cancer Center a grant worth $37 million over five years and renewed the center’s designation as a “comprehensive cancer center.”
Signing an institutional agreement with the National Cancer Centre of Singapore (NCCS). NCCS leadership from left: Deputy Chief Executive Officer for clinical operations Lim Soon Thye; NCCS Chief Executive Officer William Hwang; and Ivy Ng, Group Chief Executive Officer for Singapore Health Services.
News Release

U-M to partner with Singapore hospital, cancer center

Institutional partnerships will foster international collaboration around research, education, cancer care and outcomes
TrEC Program members and participants 2022
News Release

Program gives undergrads a ‘pathway’ to cancer careers

A 2-week summer program offers opportunity to students beyond U-M’s Ann Arbor campus
  • 3
  • 4
  • 5